|
|
Article: FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE.
- Article from:
- PR Newswire
- Article date:
- April 3, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Vaccine Offers Early Protection with Only Two Doses Against the Most Commonly Circulating Rotavirus Types in the U.S.
PHILADELPHIA, April 3, 2008 /PRNewswire-FirstCall/ -- GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved ROTARIX(R) [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants. ROTARIX will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age. The U.S. Centers for Disease Control and Prevention (CDC) currently recommends that children complete the rotavirus ...